Buxue Yimu Pills for Gynecological Iron-Deficiency Anemia

Study Overview
=================
Brief Summary
-----------------
This study evaluates Buxue Yimu Pills，Ferrous Sulfate and the addition of Buxue Yimu Pills to Ferrous Sulfate in the treatment of Iron-Deficiency Anemia in adults women. One third of participanta will receive Buxue Yimu Pills, one third of participanta will receive Buxue Yimu Pills, one third of participanta will receive Ferrous Sulfate，and the another third will receive Buxue Yimu Pills and Ferrous Sulfate in combination.

Detailed Description
-----------------
Buxue Yimu Pills, Ferrous Sulfate each Improve anemia, but they do so by different machanisms. We generally treat patients with uncomplicated Iron Deficiency Anemia with oral iron due to the ease of administration，and Ferrous Sulfate is one of the most commonly used drugs. Buxue Yimu Pills consists of multiple chinses herbs including Angelica Sinensis，Astragalus，Donkey-Hide Gelatin，Herba Leonuri，Citrus etc., which gains widespread application in the treatment after women's abortion or operations of uterine cavity. Based on the characteristics above, we try to explore its clinical application value in Gynecological Iron-Deficiency Anemia.

Official Title
-----------------
Clinical Observation of The Gynecological Iron-Deficiency Anemia Treated With Buxue Yimu Pills

Conditions
-----------------
Iron-Deficiency Anemia

Intervention / Treatment
-----------------
* Drug: Buxue Yimu Pills
* Drug: Buxue Yimu Pills &Ferrous Sulfate
* Drug: Ferrous Sulfate


Participation Criteria
=================
Eligibility Criteria
-----------------
Inclusion Criteria: Subject is a female between the age of 18 and 50. Subject suffers from mild to moderate anemia with a hemoglobin between 80g/L and 110 g/L. Subject has definite gynecological etiological factors of iron deficiency Subject provides written informed consent. Exclusion Criteria: Subject underwent chronic digestive tract inflammation，uncontrolled digestive or urinary system bleeding. Subject has other complications in addition to gynecological diseases leading to iron deficiency，such as hemorrhagic diseases of hematologic system，parasitic diseases like ancylostomiasis，chronic intravascular hemolysis，mechanical hemolysis like prosthetic valve，renal dysfunction and hemodialysis. Subject is pregnant or lactating. Subject has a severe systemic disease, such as cardiovascular system Subject has a history of malignancy or radiotherapy. Subject has undergone any Iron deficiency anemia treatment including Iron supplements or blood transfusion within 1month prior to randomization. Subject has mental disorder incapable of elementary cooperations. Subject has participated in other clinical researches of medicine within 1month prior to randomization.

Ages Eligible for Study
-----------------
Minimum Age: 18 Years
Maximum Age: 50 Years

Sexes Eligible for Study
-----------------
Female

Accepts Healthy Volunteers
-----------------
No

Study Plan
=================
How is the study designed?
-----------------

Design Details

Primary Purpose: Treatment
Allocation: Randomized
Intervention Model: Parallel Assignment
Interventional Model Description: One third of participanta will receive Buxue Yimu Pills, one third of participanta will receive Buxue Yimu Pills, one third of participanta will receive Ferrous Sulfate，and the another third will receive Buxue Yimu Pills and Ferrous Sulfate in combination.
Masking: Double


Arms and Interventions

| Participant Group/Arm | Intervention/Treatment |
| --- | --- |
| Experimental: Buxue Yimu Pills<br>Buxue Yimu Pill 12g pill by mouth, twice daily | Drug: Buxue Yimu Pills<br>* Buxue Yimu Pills 12g pill by mouth, twice daily.<br>* Other names: Buxue Yimu pellets;|
| Experimental: Buxue Yimu Pills &Ferrous Sulfate<br>Buxue Yimu Pill 12g pill by mouth, twice daily and Ferrous Sulfate 0.3g tablet by mouth, three times daily | Drug: Buxue Yimu Pills &Ferrous Sulfate<br>* Buxue Yimu Pills 12g pill by mouth, twice daily and Ferrous Sulfate 0.3g tablet by mouth, three times daily<br>* Other names: Buxue Yimu pellets,Iron Sulfate;|
| Active Comparator: Ferrous Sulfate<br>Ferrous Sulfate 0.3g tablet by mouth, three times daily | Drug: Ferrous Sulfate<br>* Ferrous Sulfate 0.3g tablet by mouth, three times daily<br>* Other names: Iron Sulfate;|

What is the study measuring?
-----------------
Primary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Complete Blood Count | Anemia Related Assessment | 5 minutes | 

Secondary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| The Short Form-36 Health Survey (Sf-36) | Information about health | 10 minutes | 
| Hepatic Function | Safety Monitoring | 5 minutes | 
| Renal Function | Safety Monitoring | 5 minutes | 
| Blood Glucose | Safety Monitoring | 5 minutes | 
| Electrolyte Semiconductor Junction | Safety Monitoring | 5 minutes | 
| Electrocardiogram(ECG) | Safety Monitoring | 5 minutes | 
| Iron Metabolism index | Anemia Related Assessment | 5 minutes | 

 Terms related to the study
=================
Keywords Provided by Centre Hospitalier Valida
-----------------
Iron-Deficiency Anemia, Buxue Yimu Pills, Ferrous Sulfate, clinical observations, adult women, Metabonomics